THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ACADIAN ASSET MANAGEMENT LLC's Holding History (CIK: 0000916542)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,165,959 Value ($000) $22 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 1,089,381 Value ($000) $16 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 308,652 Value ($000) $3 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 174,594 Value ($000) $2 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 143 Value ($000) $0 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 69,309 Value ($000) $1 Avg Close $8.66 Range $7.44 - $10.42
Q1 2022
Shares 8,277 Value ($000) $77 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 5,459 Value ($000) $60 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 49,302 Value ($000) $362 Avg Close $11.19 Range $6.10 - $15.01